[177Lu]Lu-FAPI, a novel radioligand targeting FAP abundantly expressed in cancer-associated fibroblasts, has rapidly emerged as a promising theranostic agent for solid tumors with limited treatment options [12]. The gene discussed is FAP; the disease is cancer.